0
Clinical and Research News
 DOI: 10.1176/appi.pn.2014.onlineonly
Online Only Articles
Psychiatric News
Volume 49 Number 3 page 1
+

Recalling Chestnut Lodge: Seeking the Human Behind the Psychosis
The psychoanalytic method and highly individualized treatment approach at Chestnut Lodge pointed toward the contemporary focus on early detection and intervention.

Melatonin Studied for Prevention Of Delirium in Elderly Patients
New evidence suggests that low levels of the hormone melatonin are implicated in delirium and that giving melatonin or a melatonin agonist may help prevent delirium.

In Memoriam
APA honors members whose deaths were reported from January 1, 2014, to March 31, 2014.

+

Genes Play a Large Role in Opioid Dependence
There is reason to think that opioid dependence is at least 60 percent inherited. Now a genomewide association study appears to have led to the identification of major genes contributing to this risk.

High BDNF Levels May Offer Protection Against Alzheimer’s
If BDNF is a factor that helps blocks development of Alzheimer’s and other dementias, then boosting BDNF levels might someday be a way to treat or prevent them.

+

Med Check
FDA Rejects New Antipsychotic Pending More Data
FDA Bans Products From Indian Drugmaker
OxyContin Maker Submits Abuse-Resistant Pill
Prenatal Exposure To Antidepressants Doesn’t Raise Autism Risk

In Memoriam
APA honors members whose deaths were reported from September 1, 2013, to December 31, 2013.

+

Med Check
FDA Rejects New Antipsychotic Pending More Data
FDA Bans Products From Indian Drugmaker
OxyContin Maker Submits Abuse-Resistant Pill
Prenatal Exposure To Antidepressants Doesn’t Raise Autism Risk

+

Addressing Comorbid ADHD, Substance Abuse Disorder in Adolescents
Timothy Wilens, M.D. discussed his research and his theory on treating adolescents with comorbid ADHD and SUD with Psychiatric News.

Multiple Factors Affect Use of Clozapine for Schizophrenia
A recent study searches for the explanation for the low use of clozapine—the only approved drug for treatment-resistant schizophrenia.

+

Psychiatrist Honored for Research, Public-Health Achievements
A psychiatrist and medical college dean receives honors for his long career in schizophrenia and public mental health research and efforts to revitalize psychiatric services at a medical school.

+

Maryland Undertakes Ambitious Effort at Early ID of Psychosis
An impetus for the program was the December 2012 shooting at an elementary school in Newtown, Conn.

Overweight Linked to Deficit in Brain Areas Implicated in Bipolar Disorder
A recent study searches for the explanation for the low use of clozapine—the only approved drug for treatment-resistant schizophrenia.

Imaging Data Suggest Why Some Memories Remain Vivid, Even in AD
The orbitofrontal cortex plays a major role in emotionally charged remembering. And since patients with frontotemporal dementia are not good at such remembering, their disease may have damaged their orbitofrontal cortex.

+

APA Members Win Prestigious Sarnat, Gralnick Awards
The Institute of Medicine’s 2013 Rhoda and Bernard Sarnat International Prize in Mental Health has been awarded to William Carpenter, M.D. , and Vincenzo De Luca, M.D., is the winner of the 2013 Alexander Gralnick Award. The Gralnick Award is sponsored by the American Psychiatric Foundation.

Destructive Mining Practice Worsens Depression in Appalachia
Removal of entire mountaintops to extract the coal beneath impacts more than the environment. It also appears to raise the risk of mental health problems, particularly depression.

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles
Articles